中文| English
Home
About
Company Introduction
Vision and Mission
Subsidiary enterprises
Contact Us
Ability
Core business
Brand Story
Core Advantages
Blog
Company News
Investor Relations
Sustainable
Our Commitment
Our goal
Our actions
Social honor
Social Responsibility Report
Cultural Heritage
Tibetan medical knowledge
File Download
Technological innovation
Evidence-based medicine
Care for Health
Consumer Q&A
Tibetan medical consultation
Human development
Why choose us?
Industry Standards
Training and Development
Employee Highlights
Release time:
2023-09-23 16:11
Previous page
Tibetan medicine has once again earned a world-class honor—the “Four Medical Tantras” have been inscribed on the UNESCO Memory of the World Register.
Next page
The Key to High-Quality Development of Tibetan Medicine: Building and Applying a Modern Research Model for Tibetan Medicines Under the Guidance of Tibetan Medical Theory
Recommended News
奇正藏药荣膺"中药现代化三十年示范单位" ,核心产品入选示范品种
2026-05-25
Inheriting Wisdom, Safeguarding Life: Qizheng Tibetan Medicine Celebrates Its 30th Anniversary
2025-12-27
Qizheng Tibetan Medicine Upgrades its Board of Directors’ Special Committees: Deep Integration of Strategic Investment and ESG to Drive Sustainable Development
2025-11-30
Qizheng Tibetan Medicine Receives the 2025 Ram Charan Management Practice Excellence Award—Sustainable Management Model Gains Further Recognition
2025-11-06
Free to claim! The first-ever health education guide on Tibetan Thangka, a UNESCO Intangible Cultural Heritage, is now available—both online and offline!
2025-10-14
Liu Kailie of Qizheng Tibetan Medicine: Using the modernization of Tibetan medicine as the key, we can unlock the door to the era of greater health.
2025-08-29
Ethnic traditional medicines focus on efficacy.
A Letter from the Chairman: To Each of You, My Fellow Colleagues—Written on the 30th Anniversary of Qizheng Tibetan Medicine’s Establishment
2025-08-26
In the first half of the year, Qizheng Tibetan Medicine’s net profit excluding non-recurring items increased by 27.36%. The company plans to distribute a cash dividend of 2.2 yuan for every 10 shares in the interim period.
2025-08-25
Announcement of the New Version of the Instruction Manual for Baijie Pills (0.8g per pill)
2025-08-07